Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter

Eur J Intern Med. 2023 Jul:113:104-106. doi: 10.1016/j.ejim.2023.03.020. Epub 2023 Mar 22.

Authors

Alfredo Jose Pardo-Cabello¹, Victoria Manzano-Gamero², Juan de Dios Luna³

Affiliations

¹ Department of Internal Medicine, Hospital Universitario San Cecilio, Granada Spain. Electronic address: alfredoj.pardo.sspa@juntadeandalucia.es.
² Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada Spain.
³ Department of Biostatistics, Faculty of Medicine, University of Granada, Granada Spain.

No abstract available

Keywords: Ad26COVS1; Adverse drug reaction; COVID-19 Vaccines; CX-024414; ChAdOx1 nCoV-19; Tozinameran.

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Drug-Related Side Effects and Adverse Reactions*
Humans
Vaccination
Vaccines*

Substances

COVID-19 Vaccines
Vaccines